|
|
Volumn 14, Issue 11, 2015, Pages 737-738
|
|
Antibacterial antibodies gain traction
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
514 G3;
ACTOXUMAB;
ANTIBIOTIC AGENT;
AR 301;
ASN 100;
BEZLOTOXUMAB;
BISPECIFIC ANTIBODY;
CLOSTRIDIUM DIFFICILE TOXIN A;
CLOSTRIDIUM DIFFICILE TOXIN B;
EXOPOLYSACCHARIDE;
LEUKOCIDIN;
MEDI 3902;
MEDI 4893;
MONOCLONAL ANTIBODY;
PANOBACUMAB;
SHIGAMAB;
STAPHYLOCOCCUS ALPHA TOXIN;
UNCLASSIFIED DRUG;
ANTIINFECTIVE AGENT;
BACTERIUM ANTIBODY;
BIOLOGICAL FACTOR;
ANTIBIOTIC RESISTANCE;
ARTICLE;
BACTERIAL STRAIN;
BACTERIAL VIRULENCE;
BINDING AFFINITY;
BIOFILM;
CARDIOVASCULAR DISEASE;
CELL DAMAGE;
CELL KILLING;
CLOSTRIDIUM DIFFICILE INFECTION;
CYSTIC FIBROSIS;
DIARRHEA;
DISEASE EXACERBATION;
DRUG INDUSTRY;
HEALTH CARE NEED;
HEMOLYTIC UREMIC SYNDROME;
HOSPITAL ACQUIRED PNEUMONIA;
HOSPITALIZATION;
HUMAN;
IMMUNE EVASION;
IMMUNE RESPONSE;
IN VITRO STUDY;
INFLAMMATION;
INTENSIVE CARE UNIT;
LICENSING;
LUNG FUNCTION;
LUNG INFECTION;
MACROPHAGE;
NEOPLASM;
NEUTROPHIL;
NONHUMAN;
PAIN;
PATIENT CARE;
PEPTOCLOSTRIDIUM DIFFICILE;
PHASE 1 CLINICAL TRIAL (TOPIC);
PHASE 2 CLINICAL TRIAL (TOPIC);
PHASE 3 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
PROPHYLAXIS;
PSEUDOMONAS AERUGINOSA;
PSEUDOMONAS INFECTION;
PUBLIC HEALTH;
REIMBURSEMENT;
RISK ASSESSMENT;
STAPHYLOCOCCUS AUREUS;
STAPHYLOCOCCUS INFECTION;
TYPE III SECRETION SYSTEM;
UNITED STATES;
VENTILATOR ASSOCIATED PNEUMONIA;
ANIMAL;
BACTERIAL INFECTIONS;
IMMUNOLOGY;
PROCEDURES;
TRENDS;
ANIMALS;
ANTI-BACTERIAL AGENTS;
ANTIBODIES, BACTERIAL;
BACTERIAL INFECTIONS;
BIOLOGICAL FACTORS;
CLINICAL TRIALS, PHASE III AS TOPIC;
DRUG INDUSTRY;
HUMANS;
|
|
EID: 84945970262
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd4770 Document Type: Article |
|
Times cited : (35)
|
|
References (0)
|
